Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism

This study has been completed.
Sponsor:
Information provided by:
Gulhane School of Medicine
ClinicalTrials.gov Identifier:
NCT01107067
First received: April 19, 2010
Last updated: NA
Last verified: May 2008
History: No changes posted

April 19, 2010
April 19, 2010
June 2008
December 2009   (final data collection date for primary outcome measure)
paraoxonase level after testosterone treatment
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism
Phase IV Study to Investigate the Effect of Testosterone Treatment on Paraoxonase Level in Male Patients With Hypogonadotrophic Hypogonadism

The purpose of this study is investigating the effect of testosterone treatment on paraoxonase level in male patients with hypogonadotrophic hypogonadism

Not Provided
Interventional
Phase 4
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Screening
Hypogonadism
Drug: Sustanon
250 mg/21 days
Other Name: no name
Experimental: testosterone replacement therapy
Intervention: Drug: Sustanon
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
32
December 2009
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Volunteers patients with hypogonadism

Exclusion Criteria:

  • Coronary heart disease
  • Other pituitary/hypothalamic disorders or other non-hypogonadism diseases
  • None was receiving vitamins, lipid-lowering drugs, or other medications known to interfere with PON1 activity, lipid profile, or gonadal function
Male
20 Years to 25 Years
No
Contact information is only displayed when the study is recruiting subjects
Turkey
 
NCT01107067
aa001
No
Gulhane School of Medicine Department of Endocrinology and Metabolism
Gulhane School of Medicine
Not Provided
Not Provided
Gulhane School of Medicine
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP